Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-05-06

AUTHORS

Zhengfei Zhu, Wei Liu, Michael Gillin, Daniel R Gomez, Ritsuko Komaki, James D Cox, Radhe Mohan, Joe Y Chang

ABSTRACT

BackgroundWe assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally recurrent lesions.MethodsWorst-case dose distributions were generated for each of 9 patients who experienced recurrence after concurrent chemotherapy and PSPT to 74 Gy(RBE) for stage III NSCLC by simulating and incorporating uncertainties associated with set-up, respiration-induced organ motion, and proton range in the planning process. The worst-case CT scans were then fused with the positron emission tomography (PET) scans to locate the recurrence.ResultsAlthough the volumes enclosed by the prescription isodose lines in the worst-case dose distributions were consistently smaller than enclosed volumes in the nominal plans, the target dose coverage was not significantly affected: only one patient had a recurrence outside the prescription isodose lines in the worst-case plan.ConclusionsPSPT is a relatively robust technique. Local recurrence was not associated with target underdosage resulting from estimated uncertainties in 8 of 9 cases. More... »

PAGES

108

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1748-717x-9-108

DOI

http://dx.doi.org/10.1186/1748-717x-9-108

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1040675923

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24886059


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proton Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.452404.3", 
          "name": [
            "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
            "Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Zhengfei", 
        "id": "sg:person.0617674313.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617674313.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Wei", 
        "id": "sg:person.012675337257.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012675337257.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gillin", 
        "givenName": "Michael", 
        "id": "sg:person.0602322775.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602322775.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gomez", 
        "givenName": "Daniel R", 
        "id": "sg:person.01316743567.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316743567.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komaki", 
        "givenName": "Ritsuko", 
        "id": "sg:person.07500134657.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07500134657.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cox", 
        "givenName": "James D", 
        "id": "sg:person.0734411024.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734411024.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mohan", 
        "givenName": "Radhe", 
        "id": "sg:person.0753152401.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753152401.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "Joe Y", 
        "id": "sg:person.014351135104.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014351135104.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2014-05-06", 
    "datePublishedReg": "2014-05-06", 
    "description": "BackgroundWe assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally recurrent lesions.MethodsWorst-case dose distributions were generated for each of 9 patients who experienced recurrence after concurrent chemotherapy and PSPT to 74 Gy(RBE) for stage III NSCLC by simulating and incorporating uncertainties associated with set-up, respiration-induced organ motion, and proton range in the planning process. The worst-case CT scans were then fused with the positron emission tomography (PET) scans to locate the recurrence.ResultsAlthough the volumes enclosed by the prescription isodose lines in the worst-case dose distributions were consistently smaller than enclosed volumes in the nominal plans, the target dose coverage was not significantly affected: only one patient had a recurrence outside the prescription isodose lines in the worst-case plan.ConclusionsPSPT is a relatively robust technique. Local recurrence was not associated with target underdosage resulting from estimated uncertainties in 8 of 9 cases.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1748-717x-9-108", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2421477", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438826", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2435408", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2473081", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "keywords": [
      "non-small cell lung cancer", 
      "stage III non-small cell lung cancer", 
      "phase II trial", 
      "cell lung cancer", 
      "prescription isodose line", 
      "positron emission tomography", 
      "II trial", 
      "local recurrence", 
      "lung cancer", 
      "isodose line", 
      "worst-case dose distribution", 
      "target dose coverage", 
      "concurrent chemotherapy", 
      "dose distribution", 
      "recurrent lesions", 
      "proton therapy plans", 
      "CT scan", 
      "dose coverage", 
      "target underdosage", 
      "recurrence", 
      "secondary analysis", 
      "emission tomography", 
      "patients", 
      "therapy plans", 
      "cancer", 
      "proton therapy", 
      "respiration-induced organ motion", 
      "organ motion", 
      "trials", 
      "nominal plan", 
      "chemotherapy", 
      "BackgroundWe", 
      "therapy", 
      "lesions", 
      "tomography", 
      "worst-case plans", 
      "scans", 
      "underdosage", 
      "PSPT", 
      "volume", 
      "plan", 
      "cases", 
      "lines", 
      "appearance", 
      "regard", 
      "analysis", 
      "coverage", 
      "distribution", 
      "proton range", 
      "technique", 
      "method", 
      "range", 
      "planning process", 
      "motion", 
      "process", 
      "robust technique", 
      "uncertainty", 
      "set", 
      "robustness", 
      "scenario method"
    ], 
    "name": "Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial", 
    "pagination": "108", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1040675923"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1748-717x-9-108"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24886059"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1748-717x-9-108", 
      "https://app.dimensions.ai/details/publication/pub.1040675923"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_619.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1748-717x-9-108"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-9-108'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-9-108'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-9-108'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-9-108'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      20 PREDICATES      96 URIs      88 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1748-717x-9-108 schema:about N1c0e1abc845b4a66b9335ef139864415
2 N1c90ff95a825483996185bc1b40aeaa1
3 N540090397f2f4e2db1fa334c936d6161
4 N7c888ee065b0407b85fed70e77c205cf
5 N98f29e7e5c074385910e3fd4c4e9d690
6 N9b67560c8e074992a787a1e57ae86b5f
7 Nc6c0476f73ed401ca309cde59b3c1a52
8 Nc7ba063deba14d65977f2101058a49bb
9 Nd7134bd8ee044bf9a0ec36617870c515
10 Nf00fce18fc71426a81d0c9b3e65401b3
11 Nfe23c44226244b31a78a53bd3c1d6c00
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N640c44565c9846f7a262448cd047ca13
15 schema:datePublished 2014-05-06
16 schema:datePublishedReg 2014-05-06
17 schema:description BackgroundWe assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by using the worst-case scenario method, and compared the worst-case dose distributions with the appearance of locally recurrent lesions.MethodsWorst-case dose distributions were generated for each of 9 patients who experienced recurrence after concurrent chemotherapy and PSPT to 74 Gy(RBE) for stage III NSCLC by simulating and incorporating uncertainties associated with set-up, respiration-induced organ motion, and proton range in the planning process. The worst-case CT scans were then fused with the positron emission tomography (PET) scans to locate the recurrence.ResultsAlthough the volumes enclosed by the prescription isodose lines in the worst-case dose distributions were consistently smaller than enclosed volumes in the nominal plans, the target dose coverage was not significantly affected: only one patient had a recurrence outside the prescription isodose lines in the worst-case plan.ConclusionsPSPT is a relatively robust technique. Local recurrence was not associated with target underdosage resulting from estimated uncertainties in 8 of 9 cases.
18 schema:genre article
19 schema:isAccessibleForFree true
20 schema:isPartOf N1998f5d4ccd04446b27f11da3087854f
21 Neae3e98cd19f49bb8251743ac270c323
22 sg:journal.1036451
23 schema:keywords BackgroundWe
24 CT scan
25 II trial
26 PSPT
27 analysis
28 appearance
29 cancer
30 cases
31 cell lung cancer
32 chemotherapy
33 concurrent chemotherapy
34 coverage
35 distribution
36 dose coverage
37 dose distribution
38 emission tomography
39 isodose line
40 lesions
41 lines
42 local recurrence
43 lung cancer
44 method
45 motion
46 nominal plan
47 non-small cell lung cancer
48 organ motion
49 patients
50 phase II trial
51 plan
52 planning process
53 positron emission tomography
54 prescription isodose line
55 process
56 proton range
57 proton therapy
58 proton therapy plans
59 range
60 recurrence
61 recurrent lesions
62 regard
63 respiration-induced organ motion
64 robust technique
65 robustness
66 scans
67 scenario method
68 secondary analysis
69 set
70 stage III non-small cell lung cancer
71 target dose coverage
72 target underdosage
73 technique
74 therapy
75 therapy plans
76 tomography
77 trials
78 uncertainty
79 underdosage
80 volume
81 worst-case dose distribution
82 worst-case plans
83 schema:name Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial
84 schema:pagination 108
85 schema:productId N01bf88984e53419a92bf7c378f51172e
86 N7c4185e9b8be40fba538398ce91a9018
87 N8753cb7495384d83a3914d31c50b2128
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040675923
89 https://doi.org/10.1186/1748-717x-9-108
90 schema:sdDatePublished 2022-12-01T06:31
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N4b68c3dfaa6542f984797c2c733ef434
93 schema:url https://doi.org/10.1186/1748-717x-9-108
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N01bf88984e53419a92bf7c378f51172e schema:name pubmed_id
98 schema:value 24886059
99 rdf:type schema:PropertyValue
100 N1998f5d4ccd04446b27f11da3087854f schema:issueNumber 1
101 rdf:type schema:PublicationIssue
102 N1c0e1abc845b4a66b9335ef139864415 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Retrospective Studies
104 rdf:type schema:DefinedTerm
105 N1c90ff95a825483996185bc1b40aeaa1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Follow-Up Studies
107 rdf:type schema:DefinedTerm
108 N23450f706a224aa0a1b913e937b78388 rdf:first sg:person.012675337257.44
109 rdf:rest Nb9e873d812f64151b6c45b4479311284
110 N26682536100349c4ac41e0c6688f6f58 rdf:first sg:person.07500134657.59
111 rdf:rest Ndcdb8f12ba0640cd8c3646dce41a2aea
112 N4b68c3dfaa6542f984797c2c733ef434 schema:name Springer Nature - SN SciGraph project
113 rdf:type schema:Organization
114 N540090397f2f4e2db1fa334c936d6161 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Humans
116 rdf:type schema:DefinedTerm
117 N640c44565c9846f7a262448cd047ca13 rdf:first sg:person.0617674313.51
118 rdf:rest N23450f706a224aa0a1b913e937b78388
119 N7c4185e9b8be40fba538398ce91a9018 schema:name dimensions_id
120 schema:value pub.1040675923
121 rdf:type schema:PropertyValue
122 N7c888ee065b0407b85fed70e77c205cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Neoplasm Recurrence, Local
124 rdf:type schema:DefinedTerm
125 N81a4b6faa3a8406ebd5224fae3e7fc7f rdf:first sg:person.014351135104.56
126 rdf:rest rdf:nil
127 N8753cb7495384d83a3914d31c50b2128 schema:name doi
128 schema:value 10.1186/1748-717x-9-108
129 rdf:type schema:PropertyValue
130 N98f29e7e5c074385910e3fd4c4e9d690 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Carcinoma, Non-Small-Cell Lung
132 rdf:type schema:DefinedTerm
133 N9b67560c8e074992a787a1e57ae86b5f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Prospective Studies
135 rdf:type schema:DefinedTerm
136 Nb9e873d812f64151b6c45b4479311284 rdf:first sg:person.0602322775.45
137 rdf:rest Neeea68abaf0441cb98b94aa6d8be7785
138 Nc6c0476f73ed401ca309cde59b3c1a52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Lung Neoplasms
140 rdf:type schema:DefinedTerm
141 Nc7ba063deba14d65977f2101058a49bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Prognosis
143 rdf:type schema:DefinedTerm
144 Nd7134bd8ee044bf9a0ec36617870c515 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Neoplasm Staging
146 rdf:type schema:DefinedTerm
147 Ndcdb8f12ba0640cd8c3646dce41a2aea rdf:first sg:person.0734411024.14
148 rdf:rest Nef52b4a96ca84204b36c3ff8fea719d3
149 Neae3e98cd19f49bb8251743ac270c323 schema:volumeNumber 9
150 rdf:type schema:PublicationVolume
151 Neeea68abaf0441cb98b94aa6d8be7785 rdf:first sg:person.01316743567.44
152 rdf:rest N26682536100349c4ac41e0c6688f6f58
153 Nef52b4a96ca84204b36c3ff8fea719d3 rdf:first sg:person.0753152401.18
154 rdf:rest N81a4b6faa3a8406ebd5224fae3e7fc7f
155 Nf00fce18fc71426a81d0c9b3e65401b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Survival Rate
157 rdf:type schema:DefinedTerm
158 Nfe23c44226244b31a78a53bd3c1d6c00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Proton Therapy
160 rdf:type schema:DefinedTerm
161 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
162 schema:name Medical and Health Sciences
163 rdf:type schema:DefinedTerm
164 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
165 schema:name Oncology and Carcinogenesis
166 rdf:type schema:DefinedTerm
167 sg:grant.2421477 http://pending.schema.org/fundedItem sg:pub.10.1186/1748-717x-9-108
168 rdf:type schema:MonetaryGrant
169 sg:grant.2435408 http://pending.schema.org/fundedItem sg:pub.10.1186/1748-717x-9-108
170 rdf:type schema:MonetaryGrant
171 sg:grant.2438826 http://pending.schema.org/fundedItem sg:pub.10.1186/1748-717x-9-108
172 rdf:type schema:MonetaryGrant
173 sg:grant.2473081 http://pending.schema.org/fundedItem sg:pub.10.1186/1748-717x-9-108
174 rdf:type schema:MonetaryGrant
175 sg:journal.1036451 schema:issn 1748-717X
176 schema:name Radiation Oncology
177 schema:publisher Springer Nature
178 rdf:type schema:Periodical
179 sg:person.012675337257.44 schema:affiliation grid-institutes:grid.240145.6
180 schema:familyName Liu
181 schema:givenName Wei
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012675337257.44
183 rdf:type schema:Person
184 sg:person.01316743567.44 schema:affiliation grid-institutes:grid.240145.6
185 schema:familyName Gomez
186 schema:givenName Daniel R
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316743567.44
188 rdf:type schema:Person
189 sg:person.014351135104.56 schema:affiliation grid-institutes:grid.240145.6
190 schema:familyName Chang
191 schema:givenName Joe Y
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014351135104.56
193 rdf:type schema:Person
194 sg:person.0602322775.45 schema:affiliation grid-institutes:grid.240145.6
195 schema:familyName Gillin
196 schema:givenName Michael
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0602322775.45
198 rdf:type schema:Person
199 sg:person.0617674313.51 schema:affiliation grid-institutes:grid.452404.3
200 schema:familyName Zhu
201 schema:givenName Zhengfei
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617674313.51
203 rdf:type schema:Person
204 sg:person.0734411024.14 schema:affiliation grid-institutes:grid.240145.6
205 schema:familyName Cox
206 schema:givenName James D
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734411024.14
208 rdf:type schema:Person
209 sg:person.07500134657.59 schema:affiliation grid-institutes:grid.240145.6
210 schema:familyName Komaki
211 schema:givenName Ritsuko
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07500134657.59
213 rdf:type schema:Person
214 sg:person.0753152401.18 schema:affiliation grid-institutes:grid.240145.6
215 schema:familyName Mohan
216 schema:givenName Radhe
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753152401.18
218 rdf:type schema:Person
219 grid-institutes:grid.240145.6 schema:alternateName Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
220 Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
221 schema:name Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
222 Departments of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
223 rdf:type schema:Organization
224 grid-institutes:grid.452404.3 schema:alternateName Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
225 schema:name Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
226 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...